Ciudad Paraíso: Territorio de Tensiones y Conflictos

Seed and oil References

1. Jellin JM, Batz F, Hitchens K. Natural Medicines Comprehensive Database. Stockton, CA: Therapeutic Research Faculty, 2002:1530.

2. Lucas EA, Wild RD, Hammond LJ et al. Flaxseed improves lipid profile without alter-ing biomarkers of bone metabolism in postmenopausal women. J Clin Endocrinol Metab 2002; 87:1527–1532.

3. Jenkins DJ, Kendall CW, Vidgen E et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled crossover trial. Am J Clin Nutr 1999; 69:395–402.

4. Hutchins AM, Martini MC, Olson BA et al. Flaxseed consumption influences endo-genous hormone concentrations in postmenopausal women. Nutr Cancer 2001;

39:58–65.

5. Haggans CJ, Travelli EJ, Thomas W et al. The effect of flaxseed and wheat bran consumption on urinary estrogen metabolites in premenopausal women. Cancer Epidemiol Biomarker Prev 2000; 9:719–725.

6. Haggans CJ, Hutchins AM, Olson BA et al. Effect of flaxseed consumption on uri-nary estrogen metabolites in postmenopausal women. Nutr Cancer 1999; 33:188–195.

7. Phipps WR, Martini MC, Lampe JW, Slavin JL, Kurzer MS. Effect of flax seed ingestion on the menstrual cycle. J Clin Endocrinol Metab 1993; 77:1215–1219.

8. Kurzer MS, Lampe JW, Martini MC, Adlercreutz H. Fecal lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Cancer Epidemiol Biomarkers Prev 1995; 4:353–358.

9. Bougnoux P, Koscielny S, Chajes V et al. alpha-Linolenic acid content of adipose breast tissue: a host determinant of the risk of early metastasis in breast cancer. Br J Cancer 1994; 70:330–334.

10. Plu-Bureau G, Thalabard JC, Sitruk-Ware R, Asselain B, Mauvais-Jarvis P. Cyclical mastalgia as a marker of breast cancer susceptibility: results of a case-control study among French women. Br J Cancer 1992; 65:945–949.

11. Tarpila S, Kivinen A. Ground flaxseed is an effective hypolipidemic bulk laxative [published abstract]. Gastroenterology 1997; 112:A836.

12. Lemay A, Dodin S, Kadri N et al. Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women. Obstet Gynecol 2002; 100:495–504.

13. Cunnane SC, Ganguli S, Menard C et al. High alpha-linolenic acid flaxseed (Linum usitatissimum): some nutritional properties in humans. Br J Nutr 1993; 69:443–453.

14. Glauber H, Wallace P, Griver K, Brechtel G. Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus. Ann Intern Med 1988;

108:663–668.

15. Singer P, Jaeger W, Berger I et al. Effects of dietary oleic, linoleic and alpha-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension. J Hum Hypertens 1990;

4:227–233.

16. Berry EM, Hirsch J. Does dietary linolenic acid influence blood pressure? Am J Clin Nutr 1986; 44:336–340.

17. Hu FB, Stampfer MJ, Manson JE et al. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999;

69:890–897.

18. Goss PE, Li T, Theriault M et al. Effects of dietary flaxseed in women with cyclical mastalgia. Breast Cancer Res Treat 2000; 64:49.

19. Clark WF, Kortas C, Heidenheim AP et al. Flaxseed in lupus nephritis: a two-year nonplacebo-controlled crossover study. J Am Coll Nutr 2001; 20:143–148.

20. Clark WF, Parbtani A, Huff MW et al. Flaxseed: a potential treatment for lupus nephritis. Kidney Int 1995; 48:475–480.

21. Suttmann U, Ockenga J, Schneider H et al. Weight gain and increased concentrations of receptor proteins for tumor necrosis factor after patients with symptomatic HIV infection received fortified nutrition support. J Am Diet Assoc 1996; 96:565–569.

22. Demark-Wahnefried W, Price DT, Polascik TJ et al. Pilot study of dietary fat restric-tion and flaxseed supplementarestric-tion in men with prostate cancer before surgery: explor-ing the effects on hormonal levels, prostate-specific antigen, and histopathologic features. Urology 2001; 58:47–52.

23. Anonymous. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico. Lancet 1999;

354:447–455.

24. Tou JC, Chen J, Thompson LU. Flaxseed and its lignan precursor, secoisolari-ciresinol diglycoside, affect pregnancy outcome and reproductive development in rats. J Nutr 1998; 128:1861–1868.

25. Collins TF, Sprando RL, Black TN et al. Effects of flaxseed and defatted flaxseed meal on reproduction and development in rats. Food Chem Toxicol 2003;

41:819–834.

26. Tou JC, Chen J, Thompson LU. Dose, timing, and duration of flaxseed exposure affect reproductive indices and sex hormone levels in rats. J Toxicol Environ Health A 1999; 56:555–570.

27. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HH. Potential value of plants as sources of new antifertility agents II. J Pharm Sci 1975; 64:717–753.

28. Wiesenfeld PW, Babu US, Collins TF et al. Flaxseed increased alpha-linolenic and eicosapentaenoic acid and decreased arachidonic acid in serum and tissues of rat dams and offspring. Food Chem Toxicol 2003; 41:841–855.

29. Flynn TJ, Collins TF, Sprando RL et al. Developmental effects of serum from flaxseed-fed rats on cultured rat embryos. Food Chem Toxicol 2003; 41:835–840.

30. Ward WE, Chen J, Thompson LU. Exposure to flaxseed or its purified lignan during suckling only or continuously does not alter reproductive indices in male and female offspring. J Toxicol Environ Health A 2001; 64:567–577.

31. Sprando RL, Collins TF, Wiesenfeld P et al. Testing the potential of flaxseed to affect spermatogenesis: morphometry. Food Chem Toxicol 2000; 38:887–892.

32. Sprando RL, Collins TF, Black TN et al. The effect of maternal exposure to flaxseed on spermatogenesis in F generation rats. Food Chem Toxicol 2000; 38:325–334.

33. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HH. Potential value of plants as sources of new antifertility agents I. J Pharm Sci 1975; 64:535–598.

34. Bettger WJ, DiMichelle-Ranalli E, Dillingham B, Blackadar CB. Nervonic acid is transferred from the maternal diet to milk and tissues of suckling rat pups. J Nutr Biochem 2003; 14:160–165.

35. Soita HW, Meier JA, Fehr M et al. Effects of flaxseed supplementation on milk production, milk fatty acid composition and nutrient utilization by lactating dairy cows. Arch Tierernahr 2003; 57:107–116.

36. Petit HV. Digestion, milk production, milk composition, and blood composition of dairy cows fed whole flaxseed. J Dairy Sci 2002; 85:1482–1490.

37. Ward WE, Yuan YV, Cheung AM, Thompson LU. Exposure to flaxseed and its puri-fied lignan reduces bone strength in young but not older male rats. J Toxicol Environ Health A 2001; 63:53–65.

38. Brinker F. The Toxicology of Botanical Medicines. Sandy, OR: Eclectic Medical Publications, 2000:296.

39. www.naturalstandard.com. Flaxseed and Flaxseed Oil (Linum usitatissimum) Natural Standard Monograph.

40. Tan KP, Chen J, Ward WE, Thompson LU. Mammary gland morphogenesis is enhanced by exposure to flaxseed or its major lignan during suckling in rats. Exp Biol Med (Maywood) 2004; 229:147–157.

41. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. Montvale, NJ:

Medical Economics Company, 1998.

42. Cunnane SC, Hamadeh MJ, Liede AC et al. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 1995; 61:62–68.

43. The Review of Natural Products by Facts and Comparisons. St. Louis, MO: Wolters Kluwer Co., 1999.

44. Jenkins DJ, Kendall CWC, Vidgen E et al. Health aspects of partially defatted flaxseed, including effects on serum lipids, oxidative measures, and ex vivo androgen and progestin activity: a controlled, crossover trial. Am J Clin Nutr 1999;

69:395–402.

45. Prasad K. Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.

Atherosclerosis 1997; 132:69–76.

46. Prasad K, Mantha SV, Muir AD, Westcott ND. Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid. Atherosclerosis 1998; 136:367–375.

47. Bierenbaum ML, Reichstein R, Watkins TR. Reducing atherogenic risk in hyper-lipemic humans with flaxseed supplementation: a preliminary report. J Am Coll Nutr 1993; 12:501–504.

48. Thompson LU, Rickard SE, Cheung F et al. Variability in anticancer lignan levels in flaxseed. Nutr Cancer 1997; 27:26–30.

49. Kilkkinen A, Stumpf K, Pietinen P et al. Determinants of serum enterolactone concentration. Am J Clin Nutr 2001; 73:1094–1100.

50. Rose DP. Dietary fiber and breast cancer. Nutr Cancer 1990; 13:1–8.

51. Mousavi Y, Adlercreutz H. Enterolactone and estradiol inhibit each other’s prolifer-ative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 1992; 41:615–619.

52. Sung MK, Lautens M, Thompson LU. Mammalian lignans inhibit the growth of estrogen-independent human colon tumor cells. Anticancer Res 1998; 18:1405–1408.

53. Serraino M, Thompson LU. The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. Nutr Cancer 1992; 17:153–159.

54. Lampe JW, Martini MC, Kurzer MS et al. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 1994;

60:122–128.

55. Adlercreutz H, Fotsis T, Bannwart C et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 1986; 25:791–797.

56. Adlercreutz H. Diet, breast cancer, and sex hormone metabolism. Ann N Y Acad Sci 1990; 595:281–290.

57. Wang C, Makela T, Hase T et al. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 1994; 50:205–212.

58. Serraino M, Thompson LU. The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. Cancer Lett 1991; 60:135–142.

59. Rickard SE, Yuan YV, Thompson LU. Plasma insulin-like growth factor I levels in rats are reduced by dietary supplementation of flaxseed or its lignan secoisolariciresinol diglycoside. Cancer Lett 2000; 161:47–55.

60. Thompson LU, Rickard SE, Orcheson LJ, Seidl MM. Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis.

Carcinogenesis 1996; 17:1373–1376.

61. Allman MA, Pena MM, Pang D. Supplementation with flaxseed oil versus sunflower seed oil in healthy young men consuming a low fat diet: effects on platelet composition and function. Eur J Clin Nutr 1995; 49:169–178.

62. Singer P, Wirth M, Berger I. A possible contribution of decrease in free fatty acids to low serum triglyceride levels after diets supplemented with n-6 and n-3 polyunsaturated fatty acids. Atherosclerosis 1990; 83:167–175.

63. Nestel PJ, Pomeroy SE, Sasahara T et al. Arterial compliance in obese subjects is improved with dietary plant n-3 fatty acid from flaxseed oil despite increased LDL oxidizability. Arterioscler Thromb Vasc Biol 1997; 17:1163–1170.

64. Iso H, Sato S, Umemura U et al. Linoleic acid, other fatty acids, and the risk of stroke. Stroke 2002; 33:2086–2093.

65. Nordstrom DC, Honkanen VE, Nasu Y et al. Alpha-linolenic acid in the treatment of rheumatoid arthritis. A double-blind, placebo-controlled and randomized study:

flaxseed vs. safflower seed. Rheumatol Int 1995; 14:231–234.

66. Brinker F. Herb Contraindications and Drug Interactions. Sandy, OR: Eclectic Medical Publications, 1998.

FOXGLOVE